Klotho Neurosciences, Inc. (KLTO)
NASDAQ: KLTO · Real-Time Price · USD
0.2590
-0.0100 (-3.72%)
Feb 3, 2026, 4:00 PM EST - Market closed
Klotho Neurosciences Employees
Klotho Neurosciences had 3 employees as of December 31, 2024. The number of employees increased by 2 or 200.00% compared to the previous year.
Employees
3
Change
2
Growth
200.00%
Revenue / Employee
n/a
Profits / Employee
-$3,763,354
Market Cap
19.11M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 3 | 2 | 200.00% |
| Sep 30, 2023 | 1 | 0 | - |
| Jun 30, 2023 | 1 | -2 | -66.67% |
| Dec 31, 2022 | 1 | -2 | -66.67% |
| Mar 31, 2022 | 3 | - | - |
| Dec 31, 2011 | 1 | 0 | - |
| Dec 31, 2010 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 233 |
| IO Biotech | 78 |
| Lunai Bioworks | 29 |
| IN8bio | 17 |
| VYNE Therapeutics | 13 |
| Neuphoria Therapeutics | 8 |
| Lexaria Bioscience | 7 |
| NanoViricides | 7 |
KLTO News
- 26 days ago - Klotho Neurosciences to Present at the Biotech Showcase 2026 - PRNewsWire
- 3 months ago - Klotho Neurosciences Wins the 2025 BioTech Breakthrough 'Cell Therapy Innovation of the Year' Award - PRNewsWire
- 3 months ago - Klotho Neurosciences CEO to Attend Longevity Biotech 2025 in Boston - PRNewsWire
- 4 months ago - Klotho Neurosciences Announces Expiration of Letter of Intent - PRNewsWire
- 4 months ago - Klotho Neurosciences Signs Letter of Intent to Acquire Select Assets from Turn Biotechnologies, Anchored by $300 Million Global Pharma Partnership - PRNewsWire
- 5 months ago - Klotho Neurosciences CEO to Attend Inaugural Conference & Scientific Seminar - PRNewsWire
- 6 months ago - Klotho Neurosciences Provides Shareholder Update Highlighting Recent Milestones as It Prepares to Address $8 Billion Neurodegenerative Disease Market - PRNewsWire
- 6 months ago - Klotho Neurosciences, Inc. (KLOTHO) Initiates Manufacturing of KLTO-202 Product Candidate Using AAVnerGene's Platform Technology - PRNewsWire